A greater mHLA-DR expression is known to be associated with better outcomes in COVID-19 [32, 34, 35], and the ratio of IL-6 to mHLA-DR can serve as a valuable marker of severity since ICU admission, as suggested by Bonnet et al. [23]. This evidence concerns the gene IL6 and COVID-19.